Professor Sukwhan Bang's Team Performs "Retroperitoneal Approach Lumbar Sympathectomy" Using Da Vinci SP

Seoul St. Mary's Hospital has achieved Korea's first successful case of surgery for plantar hyperhidrosis using a single-port robot. By employing a retroperitoneal approach that does not penetrate the peritoneum, the procedure reduced the extent of the incision and the burden of recovery, presenting a new possibility for minimally invasive treatment.


On the 18th, Professor Sukwhan Bang, a urologist at Seoul St. Mary's Hospital, who successfully treated plantar hyperhidrosis for the first time in Korea using a retroperitoneal approach lumbar sympathectomy with the Da Vinci SP single-port robot, checked the patient's postoperative progress during the first outpatient visit after the surgery. Seoul St. Mary's Hospital

On the 18th, Professor Sukwhan Bang, a urologist at Seoul St. Mary's Hospital, who successfully treated plantar hyperhidrosis for the first time in Korea using a retroperitoneal approach lumbar sympathectomy with the Da Vinci SP single-port robot, checked the patient's postoperative progress during the first outpatient visit after the surgery. Seoul St. Mary's Hospital

View original image

On the 29th, Seoul St. Mary's Hospital announced that the urology team led by Professor Sukwhan Bang had successfully treated a patient with plantar hyperhidrosis on the 18th by performing a "retroperitoneal approach lumbar sympathectomy" using the Da Vinci SP single-port robot.


Plantar hyperhidrosis is a condition characterized by excessive sweating on the soles of the feet. In severe cases, it can cause shoes to become wet, unpleasant odors, and recurrent skin problems, resulting in significant discomfort in daily life. The cause is known to be hyperactivity of the lumbar sympathetic ganglia at L2 to L4.


Until now, conservative treatments such as iontophoresis and Botox injections have mainly been used, but their effects are short-lived. While surgery offers a fundamental solution, the conventional laparoscopic approach required passing through the peritoneum, which posed risks of complications such as intestinal adhesions and peritoneal irritation, and also required multiple incisions.


This surgery was performed by directly accessing the retroperitoneal space through a single incision about 2 centimeters in size on the lateral side of the abdomen. The medical team used the Da Vinci SP robot to precisely remove the L3 lumbar sympathetic ganglion located adjacent to the inferior vena cava. Not passing through the peritoneum reduced the risk of complications and minimized the incision site.


In particular, the hospital explained that by leveraging the advantages of the single-port robotic platform, which allows simultaneous insertion of a high-definition 3D camera and multi-jointed surgical instruments through a single cannula, they were able to secure a stable field of view and perform precise surgery even in the narrow retroperitoneal space.


This surgery was made possible by the accumulated experience of Seoul St. Mary's Hospital's urology department in single-port robot-assisted retroperitoneal surgeries. The medical team has actively performed Retzius-sparing techniques based on the retroperitoneal approach for prostate cancer surgeries, and stated that this anatomical expertise and proficiency in robotic surgery contributed to the successful treatment of plantar hyperhidrosis.


The patient, a woman in her 20s, said, "Because I used to sweat a lot on my feet, I avoided places where I had to remove my shoes. After the surgery, I no longer sweat, and there was hardly any pain or scarring, so I was able to quickly return to my daily life."


Professor Bang stated, "Our accumulated experience in single-port retroperitoneal robot-assisted surgery in the field of urology has now been applied to the treatment of another condition, plantar hyperhidrosis. We will continue clinical research so that this can be established as a minimally invasive treatment option in the future."



Seoul St. Mary's Hospital currently has experience with more than 7,000 robot-assisted surgeries in the field of urologic cancers, including prostate, kidney, and bladder cancer, and operates both Da Vinci Xi and SP platforms.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing